AstraZeneca
AZN
$68.53
Share price
0.39%
Change (1 day)
-6.93%
Change (1 year)
Categories
AstraZeneca (AZN) - P/B ratio
P/B ratio as of April 2024 : 5.46
According to AstraZeneca's latest financial reports the company has a price-to-book ratio of 5.46.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
AstraZeneca - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 5.33 | -6.11% |
| 2022-12-31 | 5.68 | 22.91% |
| 2021-12-31 | 4.62 | -44.86% |
| 2020-12-31 | 8.38 | -6.58% |
| 2019-12-31 | 8.97 | 33.36% |
| 2018-12-31 | 6.72 | 28.42% |
| 2017-12-31 | 5.24 | 26.54% |
| 2016-12-31 | 4.14 | -11.43% |
| 2015-12-31 | 4.67 | 2.46% |
| 2014-12-31 | 4.56 | 43.05% |
| 2013-12-31 | 3.19 | 30.18% |
| 2012-12-31 | 2.45 | -3.97% |
| 2011-12-31 | 2.55 | -8.3% |
| 2010-12-31 | 2.78 | -15.01% |
| 2009-12-31 | 3.27 | -11.54% |
| 2008-12-31 | 3.70 | -11.59% |
| 2007-12-31 | 4.18 | -21.39% |
| 2006-12-31 | 5.32 | -6.66% |
| 2005-12-31 | 5.70 | 38.15% |
| 2004-12-31 | 4.13 | -33.21% |
| 2003-12-31 | 6.18 | 15.01% |
| 2002-12-31 | 5.37 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.07 | -7.07% | 🇺🇸 USA |
 Novartis NVS | 4.07 | -25.44% | 🇨🇭 Switzerland |
 Pfizer PFE | 1.61 | -70.47% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.73 | -13.30% | 🇺🇸 USA |
 Eli Lilly LLY | 65.7 | 1,103.69% | 🇺🇸 USA |
 Sanofi SNY | 1.42 | -73.94% | 🇫🇷 France |
 Biogen BIIB | 1.89 | -65.42% | 🇺🇸 USA |
 Merck MRK | 8.44 | 54.58% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 3.29 | -39.76% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 5.09 | -6.71% | 🇬🇧 UK |